Axa’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-176,224
Closed -$17.2M 1518
2015
Q1
$17.2M Buy
176,224
+25,497
+17% +$2.49M 0.07% 287
2014
Q4
$14M Buy
150,727
+7,067
+5% +$656K 0.06% 322
2014
Q3
$9.88M Buy
143,660
+19,527
+16% +$1.34M 0.04% 380
2014
Q2
$13M Sell
124,133
-3,928
-3% -$412K 0.05% 349
2014
Q1
$10.6M Buy
128,061
+4,230
+3% +$351K 0.05% 368
2013
Q4
$8.01M Buy
123,831
+20,865
+20% +$1.35M 0.04% 418
2013
Q3
$6.52M Buy
102,966
+34,788
+51% +$2.2M 0.03% 460
2013
Q2
$2.86M Buy
+68,178
New +$2.86M 0.02% 618